新冠后纤维化，一种新型冠状病毒感染后出现的并发症。
Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection.
作者信息
Ahmad Alhiyari Mousa, Ata Fateen, Islam Alghizzawi Mohd, Bint I Bilal Ammara, Salih Abdulhadi Ahmad, Yousaf Zohaib
机构信息
Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Department of Radiology, Hamad General Hospital, Hamad Medical Corporation, PO BOX 3050, Doha, Qatar.
出版信息
IDCases. 2020 Dec 31;23:e01041. doi: 10.1016/j.idcr.2020.e01041. eCollection 2021.
SARS-COV-2 has created one of the most massive pandemics in modern history. There is a rapid accumulation of data on its epidemiology, clinical course, diagnosis, management, and complications. One of the sequelae of COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) is pulmonary fibrosis. There is a dearth of accurate data on the prevalence of pulmonary fibrosis post-COVID-19. We report a patient who developed dyspnea secondary to pulmonary fibrosis after successful treatment of COVID-19 pneumonia.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引发了现代历史上最严重的大流行之一。关于其流行病学、临床病程、诊断、治疗及并发症的数据迅速积累。新型冠状病毒肺炎（COVID-19）和急性呼吸窘迫综合征（ARDS）的后遗症之一是肺纤维化。关于COVID-19后肺纤维化的患病率，目前缺乏准确数据。我们报告了一名患者，其在COVID-19肺炎成功治疗后因肺纤维化出现呼吸困难。
Zotero 插件